Skip to main content
June 5, 2019
Public Policy Priority Health IT Safety
Statement Type Regulatory Comment
Share

In comments submitted this week to the U.S. Food and Drug Administration (FDA), the nation’s informatics professionals applauded the agency for developing a regulatory Modification Framework for Artificial Intelligence (AI)/Machine Learning (ML)-based software as a medical device (SaMD). The American Medical Informatics Association (AMIA) offered additional observations and recommendations for consideration in developing the framework further.